We design
the Next Gen Bioprinters
for advanced tissue engineering
A unique high-end bioprinting platform
To meet the challenges of tissue engineering, Poietis has developed a unique and patented bioprinting technology for the creation of complex 3D tissue models : the Next Generation Bioprinting platform (NGB)
The NGB platform combines the two best bioprinting techniques : Laser-Assisted Bioprinting (LAB) & Bio-extrusion for both Research and Clinical applications.
The NGB platform is declined in two versions:
What to expect with NGB platform
HIGH
RESOLUTION
NGB stands out as a high-end platform featuring laser-assisted bioprinting, enabling users to deposit micro droplets of cell bioink with micron-level precision.
HIGH
VERSATILITY
NGB platform offers the ability to print a variety of important inks at different viscosities, cell types and materials.
HIGH
CELL VITALITY
NGB platform uses a nozzle-free system which doesn’t harm, damage or injure the cells throughout the bioprinting process.
FROM RESEARCH
TO CLINICAL
APPLICATIONS
Accelerate the transition of your 3D printed work from research to the clinic thanks to the gateway between NGB-R (for Research use) and NGB-C (for the clinic use).
Our bioprinters
NGB-RTM
The Next Generation Bioprinter for Research applications
Provides researchers with state-of-the-art bioprinting technologies for advanced tissue engineering and translational research.
NGB-CTM
NGB-C™ Bioprinter commercialized for clinical applications
Equips hospitals and clinics with bioprinting solutions for on-site clinical use and therapeutic applications, such as implantable tissues.
Our partnerships
Poietis contributes to the medicine of tomorrow by actively collaborating with research laboratories and cell therapies centers.
First company in the world to market a GMP-compatible bioprinting platform, Poietis keeps designing innovative solutions to meet the challenges of regenerative medicine.
Poietis has built strong partnerships network:
Latest news
Do you want to know more about NGB platform?